XML 41 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segments and Geographic Data (Tables)
9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Schedule of results of operations from business segments

The consumer segment reflects operation from January 1, 2017 through January 23, 2017 the date of the sale of the consumer division to ICTV. See Note 1 Acquisitions and Dispositions for more information.

 

Three Months Ended September 30, 2017 (unaudited)

    CONSUMER     PHYSICIAN RECURRING     PROFESSIONAL     TOTAL  
Revenues   $ —     $ —     $ —      $ —  
Costs of revenues     —       —       —       —  
Gross profit     —       —       —       —  
Gross profit %                                
                                 
Allocated operating expenses:                                
Engineering and product development     —       —       —       —  
Selling and marketing expenses     —       —       —       —  
Loss on disposal of assets     594                       594  
                                 
Unallocated operating expenses     —       —       —       2,888  
      594       —       —       3,482  
Loss from continuing operations     (594 )     —       —       (3.482 )
                                 
Revaluation of asset contribution related financial instruments, net     —       —       —       326  
Interest  and other financing income, net     —       —       —       20  
                                 
Loss from continuing operations before income taxes   ($ 594 )   $ —     $ —     ($ 3,136 )
                                 

  

Three Months Ended September 30, 2016 (unaudited)

    CONSUMER     PHYSICIAN RECURRING     PROFESSIONAL     TOTAL  
Revenues   $ 6,142     $ 840     $ 276     $ 7,258  
Costs of revenues     909       461       117       1,487  
Gross profit     5,233       379       159       5,771  
Gross profit %     85.2 %     45.1 %     57.6 %     79.5 %
                                 
Allocated operating expenses:                                
Engineering and product development     243       83       —       326  
Selling and marketing expenses     3,921       591       17       4,529  
Impairment     3,518                       3,518  
Loss on sale of assets             1,731               1,731  
                                 
Unallocated operating expenses     —       —       —       2,894  
      7,682       2,405       17       12,998  
Income (loss) from continuing operations     (2,449 )     (2,026 )     142       (7,227 )
                                 
Interest and other financing income, net     —       —       —       88  
                                 
Income (loss) from continuing operations before income taxes   ($ 2,449 )   ($ 2,026 )   $ 142     ($ 7,139 )

  

Nine Months Ended September 30, 2017 (unaudited)

    CONSUMER     PHYSICIAN RECURRING     PROFESSIONAL     TOTAL  
Revenues   $ 3,539     $ —     $ —     $ 3,539  
Costs of revenues     100       —       —       100  
Gross profit     3,439       —       —       3,439  
Gross profit %     97.1 %                     97.1 %
                                 
Allocated operating expenses:                                
Engineering and product development     143       —       —       143  
Selling and marketing expenses     620       —       —       620  
      Loss on sale of assets     4,816       29       —       4,845  
Unallocated operating expenses     —       —       —       4,428  
      5,579       29       —       10,036  
Loss from continuing operations     (2,140 )     (29 )     —       (6,597 )
                                 
Revaluation of asset contribution related financial instruments, net                             2,948  
Interest  and other financing expense, net     —       —       —       (103 )
                                 
Loss from continuing operations before income taxes   ($ 2,140 )   ($ 29 )   $ —     ($ 3,752 )

 

Nine Months Ended September 30, 2016 (unaudited)

    CONSUMER     PHYSICIAN RECURRING     PROFESSIONAL     TOTAL  
Revenues   $ 25,724     $ 3,302     $ 708     $ 29,734  
Costs of revenues     5,412       1,853       330       7,595  
Gross profit     20,312       1,449       378       22,139  
Gross profit %     79.0 %     43.9 %     53.4 %     74.5 %
                                 
Allocated operating expenses:                                
Engineering and product development     779       204       —       983  
Selling and marketing expenses     16,677       2,045       35       18,757  
Impairment     3,518                       3,518  
Loss on sale of assets             1,731       843       2,574  
                                 
Unallocated operating expenses     —       —       —       9,791  
      20,974       3,980       878       35,623  
Loss from continuing operations     (662 )     (2,531 )     (500 )     (13,484 )
                                 
Interest and other financing expense, net     —       —       —       (537 )
                                 
Loss from continuing operations before income taxes   ($ 662 )   ($ 2,531 )   ($ 500 )   ($ 14,021 )
Schedule of net revenues by geographic area

For the three and nine months ended September 30, 2017 and 2016 (unaudited), net revenues by geographic area were as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2017     2016     2017     2016  
North America 1   $ —     $ 4,257     $ 2,475     $ 18,376  
Asia Pacific 2     —       744       —       2,180  
Europe (including Israel)     —       2,246       1,064       9,147  
South America     —       11       —       31  
    $ —     $ 7,258     $ 3,539     $ 29,734  
                                 
1 United States           $ 3,528     $ 2,475     $ 15,405  
1 Canada           $ 277     $ —     $ 1,506
Schedule of long-lived assets by geographic area

As of September 30, 2017 and December 31, 2016, long-lived assets by geographic area were as follows:

 

    September 30, 2017     December 31, 2016  
    (unaudited)        
North America   $ —     $ 71  
Asia Pacific     —       6  
Europe (including Israel)     —       —  
    $ —     $ 77